4th Quarter - Report

VENABLE LLP for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2026 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases FY 2026 global health research and development funding Issues related to global health

LobbyistCovered position, as disclosed
JODIE CURTIS —
LAURA A HANEN —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.